Repeated sessions of electrical stimulation to brain networks associated with memory improved verbal learning in some ...

Florida's insurance regulator is demanding detailed prescription data on millions of patients, raising alarms over patient ...

A new study suggests that women who use a popular hormonal menopause treatment later in life may be at a higher risk of developing Alzheimer’s disease.

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky ...

Hot flashes, night sweats and other symptoms of a difficult menopause could be early warning flags for dementia, a new study ...

Antidepressants have helped millions of people. But a recent scientific analysis suggests that the benefits of these drugs ...

Statistics published by the NHS Business Services Authority in its ‘Medicines Used in Mental Health’ report show an increase in both number of items prescribed and number of patients receiving these ...

Lecanemab and donanemab were hailed as 'the beginning of the end' of dementia last year, after studies showed they both ...

HCA Healthcare UK is offering amyloid-targeting therapies for patients with early-stage Alzheimer’s disease.

Lecanemab and donanemab were hailed as 'the beginning of the end' of dementia last year, after studies showed they both slowed the progression of the memory-robbing illness.

Scientists have long been racking their brains for ways to treat Alzheimer’s disease, the most common type of dementia.

For nearly five years, people with attention deficit/hyperactivity disorder have had the option of getting their stimulant medications prescribed and renewed by doctors they see only over a computer ...